|
|
Volumn 30, Issue 5, 2012, Pages 371-
|
|
Shining a light on trial data
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DAPAGLIFLOZIN;
GABAPENTIN;
OSELTAMIVIR;
ROFECOXIB;
ROSIGLITAZONE;
AVIAN INFLUENZA;
CLINICAL RESEARCH;
CLINICAL TRIAL (TOPIC);
DATA ANALYSIS;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG LEGISLATION;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GOLD STANDARD;
HEALTH CARE POLICY;
HUMAN;
INFECTION PREVENTION;
MEDICAL LITERATURE;
MEDICAL PRACTICE;
MEDICAL SOCIETY;
OUTCOME ASSESSMENT;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
VIRUS TRANSMISSION;
ACCESS TO INFORMATION;
BIOTECHNOLOGY;
CLINICAL TRIALS AS TOPIC;
DRUG AND NARCOTIC CONTROL;
DRUG APPROVAL;
DRUG INDUSTRY;
EUROPE;
HUMANS;
INFLUENZA, HUMAN;
OSELTAMIVIR;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84871611862
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2237 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|